EXPLORER
Device8 sessions of use of the device in the home and the community of the participants
NCT Number: NCT06167954
The goal of this clinical trial is to analyze the usability and safety of the robotic gait device EXPLORER in children with cerebral palsy, acquired brain injury and spinal muscular atrophy.
Participants will use the exoskeletons in their home and the community and variables regarding safety and usability will be measured and recorded.
Looking for future studies?
Notify Me2 year–17 year
All sexes
Interventional
Not applicable
Hospital Infantil Universitario Niño Jesús-Servicio de Rehabilitación, Madrid, Spain
Neurological and neuromuscular diseases are the main cause of motor disability in children, leading to the inability to stand and walk in many cases. Robotic devices are a useful tool in the rehabilitation of these children, but most of them are designed to be used in the clinical setting. EXPLORER is a robotic device designed to assist gait in children with motor disability in their homes and the community. The aim of this study is to analyze the safety and usability of the EXPLORER in children with cerebral palsy, acquired brain injury and spinal muscular atrophy.
A test phase will be conducted in order to make some final modifications and improve the device. Some participants of the sample will use the device in 1-3 occasions in a controlled environment.
After these modifications, participants will use the final version of the device in 8 different occasions in their homes and the community in order to prove its safety and usability.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8 sessions of use of the device in the home and the community of the participants
Time frame: through study completion, along 8 weeks
occurrence of any serious adverse event to the participant or the caregiver
Time frame: through study completion, along 8 weeks
Number of falling events occurred from the participant or caregiver
Time frame: through study completion, along 8 weeks
Occurrence of any injury of the skin in the areas of contact and produced by the use of the device
Time frame: through study completion, along 8 weeks
pain measured by the Visual Analogic Scale (VAS) by the participant and the caregiver, scored from 0 to 10, being 0 "no pain" and 10 "unbearable pain"
Time frame: through study completion, along 8 weeks
spasticity measured by the Modified Ashworth Scale (MAS), scored from 0 (no spasticity) to 4 (affected part in rigid flexion or extension)
Time frame: through study completion, along 8 weeks
measurement of heart rate
Time frame: through study completion, along 8 weeks
measurement of Oxygen saturation when medical prescription
Time frame: through study completion, along 8 weeks
Time to don and doff the device to each participant
Time frame: through study completion, along 8 weeks
Number of steps taken provided by the device
Time frame: through study completion, along 8 weeks
Walking time provided by the device
Time frame: through study completion, along 8 weeks
The number of times that the investigators have to intervene in the session in order to avoid damage when the device is being used by the caregiver
Time frame: at the end of the intervention, 8th week
Satisfaction of the participant (caregiver) with the device measured by the Quebec User Evaluation of Satisfaction with Assistive Technology 2.0. (QUEST 2.0), scored with a Likert type scale from 0 to 5, being 0 the lowest satisfaction and 5 the highest possible satisfaction with the device
Time frame: through study completion, along 8 weeks
measurement of blood pressure
Time frame: at the end of the intervention, 8th week
Analysis of the drop-out rate during the study period
Time frame: through study completion, along 8 weeks
Rate of the participants suitable to use the device
Time frame: through study completion, along 8 weeks
Rate of the houses suitable to use the device
Time frame: through study completion, along 8 weeks
Rate of the exterior spaces that are suitable to use the device
MarsiBionics
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05767268
Acquired Brain Injury, Brain Damage, Chronic
Bosisio Parini, Italy
View Trial DetailsNCT05914818
Acquired Brain Injury, Brain Damage, Chronic
Madrid, Spain
View Trial DetailsNCT03386968
Acquired Brain Injury, Brain Damage, Chronic
Valhalla, New York, United States
View Trial DetailsNCT02428673
Bone Diseases, Bone Diseases, Metabolic
Saint Paul, Minnesota, United States
View Trial Details